Gotham Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.5M Buy
1,051,942
+176,238
+20% +$4.69M 0.09% 295
2025
Q4
$21.8M Sell
875,704
-596,382
-41% -$15M 0.08% 356
2025
Q3
$37.5M Buy
1,472,086
+568,016
+63% +$14M 0.16% 91
2025
Q2
$21.9M Buy
904,070
+475,105
+111% +$11.1M 0.13% 169
2025
Q1
$10.9M Buy
428,965
+287,925
+204% +$7.53M 0.09% 301
2024
Q4
$3.74M Buy
141,040
+108,494
+333% +$2.94M 0.04% 580
2024
Q3
$942K Buy
32,546
+7,070
+28% +$206K 0.01% 921
2024
Q2
$713K Sell
25,476
-8,214
-24% -$226K 0.01% 980
2024
Q1
$935K Sell
33,690
-26,788
-44% -$743K 0.01% 867
2023
Q4
$1.74M Sell
60,478
-462,443
-88% -$14M 0.03% 656
2023
Q3
$17.3M Sell
522,921
-9,267
-2% -$328K 0.36% 26
2023
Q2
$19.5M Buy
532,188
+78,965
+17% +$3.07M 0.42% 16
2023
Q1
$18.5M Buy
453,223
+184,535
+69% +$7.97M 0.45% 15
2022
Q4
$13.8M Sell
268,688
-59,149
-18% -$2.84M 0.39% 24
2022
Q3
$14.3M Buy
327,837
+6,819
+2% +$331K 0.43% 19
2022
Q2
$16.8M Buy
321,018
+29,725
+10% +$1.51M 0.54% 15
2022
Q1
$15.1M Sell
291,293
-82,192
-22% -$4.26M 0.47% 16
2021
Q4
$22.1M Sell
373,485
-158,691
-30% -$7.86M 0.71% 9
2021
Q3
$22.9M Buy
532,176
+54,946
+12% +$2.43M 0.93% 8
2021
Q2
$18.7M Sell
477,230
-11,409
-2% -$444K 0.79% 8
2021
Q1
$17.7M Sell
488,639
-33,529
-6% -$1.19M 0.79% 8
2020
Q4
$19.2M Sell
522,168
-15,359
-3% -$563K 0.64% 12
2020
Q3
$18.7M Sell
537,527
-444,123
-45% -$15.6M 0.6% 17
2020
Q2
$30.5M Sell
981,650
-83,538
-8% -$2.84M 0.91% 8
2020
Q1
$33M Buy
1,065,188
+207,501
+24% +$7.07M 0.92% 5
2019
Q4
$31.9M Buy
857,687
+849,159
+9,957% +$30.2M 0.59% 32
2019
Q3
$291K Sell
8,528
-425,491
-98% -$15.5M 0.01% 918
2019
Q2
$17.8M Sell
434,019
-1,122,287
-72% -$44.6M 0.28% 99
2019
Q1
$62.7M Buy
1,556,306
+929,765
+148% +$37.2M 0.92% 7
2018
Q4
$25.9M Buy
626,541
+148,403
+31% +$6.16M 0.4% 72
2018
Q3
$20M Sell
478,138
-863,919
-64% -$33.3M 0.28% 110
2018
Q2
$46.2M Sell
1,342,057
-148,415
-10% -$5.07M 0.67% 22
2018
Q1
$50.2M Buy
1,490,472
+1,437,854
+2,733% +$49.4M 0.7% 14
2017
Q4
$1.81M Buy
52,618
+29,623
+129% +$1.01M 0.03% 506
2017
Q3
$779K Sell
22,995
-473,363
-95% -$15.2M 0.01% 636
2017
Q2
$15.8M Sell
496,358
-499,314
-50% -$15.7M 0.22% 145
2017
Q1
$32.3M Buy
995,672
+195,292
+24% +$6.16M 0.41% 49
2016
Q4
$24.7M Sell
800,380
-421,140
-34% -$12.9M 0.32% 94
2016
Q3
$39.3M Sell
1,221,520
-821,429
-40% -$27.5M 0.51% 37
2016
Q2
$68.2M Buy
2,042,949
+380,514
+23% +$12.1M 0.82% 11
2016
Q1
$46.8M Buy
+1,662,435
New +$47.5M 0.52% 25
2015
Q4
Sell
-1,104,445
Closed -$32.9M 974
2015
Q3
$32.9M Buy
1,104,445
+24,555
+2% +$787K 0.32% 108
2015
Q2
$34.4M Sell
1,079,890
-999,429
-48% -$32.6M 0.29% 119
2015
Q1
$68.6M Buy
2,079,319
+581,640
+39% +$18.5M 0.52% 31
2014
Q4
$44.3M Sell
1,497,679
-212,006
-12% -$6.08M 0.36% 88
2014
Q3
$48M Sell
1,709,685
-125,660
-7% -$3.53M 0.48% 44
2014
Q2
$51.7M Buy
1,835,345
+765,737
+72% +$21.8M 0.65% 8
2014
Q1
$32.6M Buy
1,069,608
+835,325
+357% +$24.9M 0.49% 26
2013
Q4
$6.81M Buy
234,283
+165,720
+242% +$4.82M 0.16% 209
2013
Q3
$1.87M Buy
68,563
+49,494
+260% +$1.35M 0.06% 455
2013
Q2
$507K Buy
+19,069
New +$527K 0.02% 666

Other funds holding PFE

Gotham Asset Management's PFE Position: Q1 2026 in Review

Gotham Asset Management increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $4.69M and bringing the position to 1,051,942 shares worth $29.5M. The position accounts for 0.09% of the portfolio, ranked #295.

Gotham Asset Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $68.6M in Q1 2015. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Gotham Asset Management held 1,051,942 shares of Pfizer worth $29.5M as of Q1 2026.
  • Gotham Asset Management bought 176,238 Pfizer shares in Q1 2026, an estimated $4.69M.
  • Pfizer made up 0.09% of Gotham Asset Management's portfolio in Q1 2026, its #295 holding.
  • Gotham Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • Gotham Asset Management's Pfizer position peaked at $68.6M in Q1 2015.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.